Nishinomiya, Japan

Hiromi Shimomura


Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 28(Granted Patents)


Location History:

  • Takarazuka, JA (1976)
  • Nishinomiya, JA (1978)
  • Nishinomiya, JP (1978 - 1980)
  • Hyogo, JP (1982)

Company Filing History:


Years Active: 1976-1982

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Hiromi Shimomura: Innovator in Antiviral Compounds

Introduction

Hiromi Shimomura is a prominent inventor based in Nishinomiya, Japan. She has made significant contributions to the field of chemistry, particularly in the development of antiviral agents. With a total of 6 patents to her name, her work continues to impact the scientific community.

Latest Patents

Among her latest patents is a groundbreaking invention related to tricyclic cage compounds. These compounds are synthesized for use as antiviral agents, showcasing a formula that includes various alkylene groups and functional groups that enhance their efficacy. Another notable patent involves cyclopentylacetic acid derivatives, which are prepared through a specific reaction process, further demonstrating her innovative approach to chemical synthesis.

Career Highlights

Hiromi Shimomura has established herself as a key figure in her field, working with Sumitomo Chemical Company, Limited. Her research focuses on creating compounds that are not only effective but also safe for use, addressing the critical need for antiviral solutions without side effects.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Junki Katsube and Akihiko Sugie. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.

Conclusion

Hiromi Shimomura's contributions to the field of chemistry, particularly in antiviral compounds, highlight her innovative spirit and dedication to scientific advancement. Her work continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…